Joy Kong, MD explains stem cell research for autism, covering a 2021 study using bone marrow stem cells and a 2019 study using umbilical cord cells. Both showed measurable improvements in autistic children across different treatment approaches.
The 2021 study used autologous bone marrow derived stem cells. They used one assessment tool that showed significant reduction in disease severity in the treatment group compared to control over a 12 month period. And then in a 2019 study they used allogeneic umbilical cord mics. So from somebody else they had three sections of the study and each section was given a different number of doses. So 12 children total. So some were given one treatment, some were given two, some were given three. So three separate treatments in a two month interval and 50% of these children showed improvement.
